Kol A. Zarember
- Immunology top 1%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 18
- Immune Response and Inflammation 12
- Immune Cell Function and Interaction 3
- Microbiology top 1%
- Antimicrobial Peptides and Activities 6
- Infectious Diseases top 2%
- Antifungal resistance and susceptibility 7
- Endocrinology top 5%
- Legionella and Acanthamoeba research 5
- Epidemiology top 5%
-
- Bacterial biofilms and quorum sensing 4
-
- Blood disorders and treatments 3
- Co-authors
- Paul J. GodowskiJohn I. GallinDouglas B. KuhnsOfer LevyHarry L. MalechKyung J. Kwon‐ChungYun C. ChangJanyce A. Sugui
- Journals
- New England Journal of Medicine (1 paper)Journal of Biological Chemistry (1 paper)Circulation (1 paper)
- Partner nations
- United StatesAustraliaTunisia
In The Last Decade
Kol A. Zarember
40 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Immunology 2.3k
- Microbiology 358
- Infectious Diseases 677
- Endocrinology 155
- Epidemiology 737
Countries citing papers authored by Kol A. Zarember
This map shows the geographic impact of Kol A. Zarember's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kol A. Zarember with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kol A. Zarember more than expected).
Fields of papers citing papers by Kol A. Zarember
This network shows the impact of papers produced by Kol A. Zarember. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kol A. Zarember. The network helps show where Kol A. Zarember may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kol A. Zarember, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 1 | |
| 2 | 2017 | 3 | |
| 3 | 2016 | 3 | |
| 4 | 2015 | 106 | |
| 5 | 2014 | 59 | |
| 6 | 2013 | 43 | |
| 7 | 2013 | 7 | |
| 8 | 2012 | 5 | |
| 9 | 2010 | 354 | |
| 10 | 2010 | 68 | |
| 11 | 2010 | 30 | |
| 12 | 2009 | 34 | |
| 13 | 2008 | 6 | |
| 14 | 2008 | 96 | |
| 15 | 2007 | 180 | |
| 16 | 2005 | 91 | |
| 17 | 2004 | 195 | |
| 18 | 2003 | 41 | |
| 19 | Tissue Expression of Human Toll-Like Receptors and Differential Regulation of Toll-Like Receptor mRNAs in Leukocytes in Response to Microbes, Their Products, and Cytokinesbreakdown → | 2002 | 1040 |
| 20 | 1995 | 70 |
About Kol A. Zarember
Kol A. Zarember is a scholar working on Immunology, Endocrinology and Microbiology, having authored 40 papers that have together received 3.8k indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (18 papers), Immune Response and Inflammation (12 papers), Antifungal resistance and susceptibility (7 papers), Antimicrobial Peptides and Activities (6 papers), Legionella and Acanthamoeba research (5 papers), Bacterial biofilms and quorum sensing (4 papers), Blood disorders and treatments (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Immunology (2.3k citations), Microbiology (358 citations) and Infectious Diseases (677 citations). Kol A. Zarember has collaborated with scholars based in United States, Australia and Tunisia. Frequent co-authors include Paul J. Godowski, John I. Gallin, Douglas B. Kuhns, Ofer Levy, Harry L. Malech, Kyung J. Kwon‐Chung, Yun C. Chang, Janyce A. Sugui, Suk See De Ravin and Steven M. Holland. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.